CRISPR

CRISPR1-ins

ID

ZDB-CRISPR-180614-1

Name

CRISPR1-ins

Previous Names

None

Target

ins (1)

Sequence

5' - TCCAGTGTAAGCACTAACCC - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

None

Genome Resources

None

Target Location

Constructs

No data available

Genomic Features

Genomic Feature	Affected Genomic Regions
bns102	ins

Expression

Gene expression in Wild Types + CRISPR1-ins

No data available

Phenotype

Phenotype resulting from CRISPR1-ins

No data available

Phenotype of all Fish created by or utilizing CRISPR1-ins

Phenotype	Fish	Conditions	Figures
whole organism glucose increased amount, abnormal	ins^{bns102/bns102}	control	Fig. 3, Fig. 4, Figure 1 from Mullapudi et al., 2018
whole organism glucose amount, ameliorated	ins^{bns102/bns102}	chemical treatment by environment: flutamide	Fig. 3, Fig. 4 from Mullapudi et al., 2018
whole organism glucose amount, ameliorated	ins^{bns102/bns102}	chemical treatment by environment: enzalutamide	Fig. 4 from Mullapudi et al., 2018
yolk lipid increased amount, abnormal	ins^{bns102/bns102}	standard conditions	Figure 1 from Mullapudi et al., 2018
whole organism decreased life span, abnormal	ins^{bns102/bns102}	standard conditions	Figure 1 from Mullapudi et al., 2018
whole organism glucose amount, ameliorated	ins^{bns102/bns102}	chemical treatment by environment: dapagliflozin	Fig. 3 from Mullapudi et al., 2018
whole organism glucose amount, ameliorated	ins^{bns102/bns102}	chemical treatment by environment: cyproterone	Fig. 4 from Mullapudi et al., 2018
whole organism glucose amount, ameliorated	ins^{bns102/bns102}	chemical treatment by environment: 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one	Fig. 3 from Mullapudi et al., 2018
whole organism glucose amount, ameliorated	ins^{bns102/bns102}	chemical treatment by environment: pioglitazone	Fig. 3 from Mullapudi et al., 2018
endocrine pancreas ab1-ins labeling absent, abnormal	ins^{bns102/bns102}; zf5Tg	standard conditions	Figure 1 from Mullapudi et al., 2018
whole organism glucose amount, ameliorated	ins^{bns102/bns102} + MO1-ar	control	Fig. 4 from Mullapudi et al., 2018

Citations